Does Rallies show Form 4 insider transactions for TMO?

Yes. Rallies tracks TMO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is TMO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TMO. It does not provide personalized investment advice.

TMO (Thermo Fisher) Stock Analysis - Insider Trades

Thermo Fisher (TMO) is a publicly traded Healthcare sector company. As of May 20, 2026, TMO trades at $451.13 with a market cap of $164.26B and a P/E ratio of 24.62. TMO moved +0.93% today. Year to date, TMO is -26.08%; over the trailing twelve months it is +9.19%. Its 52-week range spans $385.46 to $643.99. Analyst consensus is strong buy with an average price target of $611.60. Rallies surfaces TMO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading TMO stock inside the company?

Recent TMO insider activity includes Pettiti Gianluca sold 400, Shafer Michael D sold 1.61K, CASPER MARC N sold 20, CASPER MARC N sold 60, and CASPER MARC N sold 58. Rallies tracks insider transaction dates, shares, prices, and estimated values.

TMO Key Metrics

Key financial metrics for TMO
Metric	Value
Price	$451.13
Market Cap	$164.26B
P/E Ratio	24.62
EPS	$18.22
Dividend Yield	0.47%
52-Week High	$643.99
52-Week Low	$385.46
Volume	2.42M
Avg Volume	0
Revenue (TTM)	$45.20B
Net Income	$6.87B
Gross Margin	0.00%

Recent TMO Insider Trades

Pettiti Gianluca sold 400 (~$185.06K) on Apr 27, 2026.
Shafer Michael D sold 1.61K (~$802.54K) on Mar 11, 2026.
CASPER MARC N sold 20 (~$10.07K) on Mar 5, 2026.
CASPER MARC N sold 60 (~$30.35K) on Mar 5, 2026.
CASPER MARC N sold 58 (~$29.44K) on Mar 5, 2026.

Latest TMO News

Thermo Fisher Q1 Revenue Hits $11.01B, EPS Beats Estimates, Flags Inflation Risk — Apr 23, 2026
Thermo Fisher slides as Q1 organic growth stays muted despite reported revenue gain — Apr 23, 2026
Thermo Fisher Q1 Revenue Rises 6% to $11.01B; EPS Up and $3B Buyback — Apr 23, 2026
Thermo Fisher slides as price-target cut revives growth worries after Clario deal close — Apr 16, 2026
Thermo Fisher jumps as Clario deal momentum builds ahead of April 23 earnings — Apr 14, 2026

TMO Analyst Consensus

17 analysts cover TMO: 0 strong buy, 15 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $611.60.

Common questions about TMO

Who is trading TMO stock inside the company?: Recent TMO insider activity includes Pettiti Gianluca sold 400, Shafer Michael D sold 1.61K, CASPER MARC N sold 20, CASPER MARC N sold 60, and CASPER MARC N sold 58. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TMO?: Yes. Rallies tracks TMO insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TMO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TMO. It does not provide personalized investment advice.